1. Home
  2. TV vs CRVS Comparison

TV vs CRVS Comparison

Compare TV & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.86

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.79

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TV
CRVS
Founded
1969
2014
Country
Mexico
United States
Employees
26599
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TV
CRVS
Price
$2.86
$15.79
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$5.30
$30.17
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.86
$3.38
52 Week High
$3.49
$26.95

Technical Indicators

Market Signals
Indicator
TV
CRVS
Relative Strength Index (RSI) 44.38 51.78
Support Level $2.86 $14.24
Resistance Level $2.94 $19.21
Average True Range (ATR) 0.12 0.95
MACD -0.01 0.01
Stochastic Oscillator 30.56 62.41

Price Performance

Historical Comparison
TV
CRVS

About TV Grupo Televisa S.A.

Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: